News
The Centers for Medicare & Medicaid Services (CMS) is developing a pilot program that could change the landscape of obesity ...
On Thursday, Eli Lilly and Co.’s (NYSE:LLY) weight loss rival Novo Nordisk A/S (NYSE:NVO), along with smaller firms, Terns ...
UnitedHealthcare says it’s dropping some of its Medicare Advantage plans that collectively cover 600,000 people.
Cancer vaccine experts are worried that if the Trump administration takes a hostile posture towards mRNA broadly, cancer ...
A trial of Eli Lilly’s diabetes drug Mounjaro did not meet expectations for outperforming Trulicity in preventing heart ...
22h
Investor's Business Daily on MSNWhy S&P 500 Stock Amgen Stumbled Despite Its Beat-And-Raise QuarterAmgen stock dropped Wednesday despite a strong second quarter as investors look ahead to the next weight-loss readouts.
Regulatory update: The Centers for Medicare & Medicaid Services (CMS) finalized LTACH rules for fiscal year 2026, increasing ...
4h
LAist on MSN‘We did not want to take this guy’: Abuse rates higher at nursing homes with more mental illnessNursing homes are designed to care for patients with physical infirmities. But nationwide, 1 in 5 residents has been diagnosed with a serious mental illness, such as schizophrenia or psychosis — ...
2025 full-year guidance raised -- Net revenue guidance increased to $271 million-$277 million for fiscal 2025, implying 22% ...
Cryotherapy, infant stem cells, extreme cold, IV infusions, red light therapy, blue light therapy … more Australians are ...
Are weight loss shots like Ozempic and Wegovy safe long-term? It’s complicated. Some early studies suggest thyroid concerns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results